CO4900054A1 - Pirroles sustituidos - Google Patents

Pirroles sustituidos

Info

Publication number
CO4900054A1
CO4900054A1 CO97042636A CO97042636A CO4900054A1 CO 4900054 A1 CO4900054 A1 CO 4900054A1 CO 97042636 A CO97042636 A CO 97042636A CO 97042636 A CO97042636 A CO 97042636A CO 4900054 A1 CO4900054 A1 CO 4900054A1
Authority
CO
Colombia
Prior art keywords
alkyl
aryl
hydrogen
independently
formula
Prior art date
Application number
CO97042636A
Other languages
English (en)
Inventor
Hooda Dhingra Urvashi
Donna Mary Huryn
Dennis Dalton Keith
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CO4900054A1 publication Critical patent/CO4900054A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un compuesto de la fórmula:en la que R1 y R1´ con independencia entre sí son alquilo, arilo, alquenilo o alquinilo; R2 y R2´ con independencia entre sí son hidrógeno o alquilo; R4 , R5 , R6 , R7 , R4´ , R5´ , R6´ y R7´ con independencia entre sí son hidrógeno,O ½CH2 OCR8 , CO2 R9 , CH2 OR10 , CHO, CH2 NR11 R12 , CON(R13 )2 , halógeno, ciano, arilo, alquilo, hidroxi, alcoxi, ariloxi, haloalquilo, nitro, amino, aralquiloxi, acilamino, monoalquilamino, dialquilamino, tio, alquiltio, alquilsulfinilo, alquilsulfonilo, arilsulfinilo, azida, fosfato o fosfonato, con la condición de que por lo menos uno de R4 , R5 , R6 y R7 y por lo menos uno de R4´ , R5´ , R6´ y R7´ sea distinto de hidrógeno; con la condición de que si R6 es metoxi, entonces R5 o R5´ no son metoxi; R8 es alquilo o arilo; R9 es alquilo o arilo; R10 es hidrógeno, alquilo o arilo; R11 y R12 con independencia entre sí son hidrógeno, alquilo, arilo, aralquilo o acilo; R13 es hidrógeno, alquilo, arilo o aralquilo; yuno de X e Y significa o y el otro significa O, S, (H, OH) o (H,H); así como los productos previos farmacéuticamente aceptables de los mismos o las sales farmacéuticamente aceptables de los compuestos ácidos de la fórmula I con bases o de los compuestos básicos de la fórmula I con ácidos.
CO97042636A 1996-07-29 1997-07-25 Pirroles sustituidos CO4900054A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2207896P 1996-07-29 1996-07-29
US4849697P 1997-06-03 1997-06-03

Publications (1)

Publication Number Publication Date
CO4900054A1 true CO4900054A1 (es) 2000-03-27

Family

ID=26695475

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97042636A CO4900054A1 (es) 1996-07-29 1997-07-25 Pirroles sustituidos

Country Status (20)

Country Link
US (1) US6228877B1 (es)
EP (1) EP0915870B1 (es)
JP (1) JP2000516588A (es)
KR (1) KR20000029640A (es)
CN (1) CN1077571C (es)
AR (1) AR007969A1 (es)
AT (1) ATE224889T1 (es)
AU (1) AU740011B2 (es)
BR (1) BR9711607A (es)
CA (1) CA2262089A1 (es)
CO (1) CO4900054A1 (es)
DE (1) DE69715870T2 (es)
DK (1) DK0915870T3 (es)
ES (1) ES2183163T3 (es)
HR (1) HRP970415A2 (es)
MA (1) MA24354A1 (es)
PE (1) PE91598A1 (es)
PT (1) PT915870E (es)
TR (1) TR199900186T2 (es)
WO (1) WO1998004551A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE243693T1 (de) * 1998-03-17 2003-07-15 Hoffmann La Roche Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
MXPA02003667A (es) * 1999-10-12 2002-08-30 Hoffmann La Roche Pirroles sustituidos como agentes antiproliferativos para tratamiento del cancer.
US6559164B1 (en) 1999-10-12 2003-05-06 Hoffmann-La Roche Inc. Substituted pyrroles suitable for continuous infusion
US6313143B1 (en) 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
US6326501B1 (en) * 2000-04-19 2001-12-04 Hoffmann-La Roche Inc. Methylation of indole compounds using dimethyl carbonate
US7129250B2 (en) * 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
CA2308994A1 (en) * 2000-05-19 2001-11-19 Aegera Therapeutics Inc. Neuroprotective compounds
TW201041580A (en) 2001-09-27 2010-12-01 Alcon Inc Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
AU2002342193B2 (en) * 2001-10-29 2006-10-26 Nektar Therapeutics Al, Corporation Polymer conjugates of protein kinase C inhibitors
CA2393720C (en) * 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
RU2409579C2 (ru) 2005-02-09 2011-01-20 Аркьюл, Инк. Композиции и способы лечения рака
CN101558062A (zh) * 2006-12-19 2009-10-14 诺瓦提斯公司 作为激酶抑制剂的吲哚基马来酰亚胺衍生物
JP5425060B2 (ja) * 2007-06-22 2014-02-26 アークル インコーポレイテッド ピロリジノン、ピロリジン−2,5−ジオン、ピロリジンおよびチオスクシンイミド誘導体、癌の治療のための組成物および方法
EP2173748B1 (en) 2007-06-22 2011-08-31 ArQule, Inc. Indolyl pyrrolidines for the treatment of cancer
EP2173724B1 (en) 2007-06-22 2012-12-05 ArQule, Inc. Quinazolinone compounds and methods of use thereof
GB201111427D0 (en) * 2011-07-05 2011-08-17 Amakem Nv Novel bisindolylmaleimides, pan-pkc inhibitors
EP3741375A1 (en) 2014-07-17 2020-11-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
CN105777751B (zh) * 2016-04-26 2018-12-11 浙江工业大学 一种双芳基马来酰亚胺类化合物及其药学上可接受的盐及其制备方法和应用
CN107973785B (zh) * 2017-11-27 2019-12-31 浙江工业大学上虞研究院有限公司 一种用于检测银离子的荧光探针及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
US5380746A (en) 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
CA2015996C (en) * 1989-05-05 2001-08-28 Hartmut Osswald Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals
JPH0539289A (ja) 1991-02-15 1993-02-19 Masahiro Irie 無水マレイン酸誘導体およびその製造方法
WO1993018765A1 (en) 1992-03-20 1993-09-30 The Wellcome Foundation Limited Indole derivatives with antiviral activity
DE4217964A1 (de) 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung

Also Published As

Publication number Publication date
EP0915870A1 (en) 1999-05-19
KR20000029640A (ko) 2000-05-25
MA24354A1 (fr) 1998-07-01
CN1226248A (zh) 1999-08-18
AU4296397A (en) 1998-02-20
HRP970415A2 (en) 1998-08-31
DK0915870T3 (da) 2003-02-03
ATE224889T1 (de) 2002-10-15
AU740011B2 (en) 2001-10-25
CN1077571C (zh) 2002-01-09
WO1998004551A1 (en) 1998-02-05
PT915870E (pt) 2003-01-31
DE69715870D1 (de) 2002-10-31
BR9711607A (pt) 1999-08-24
JP2000516588A (ja) 2000-12-12
ES2183163T3 (es) 2003-03-16
AR007969A1 (es) 1999-11-24
PE91598A1 (es) 1998-12-24
TR199900186T2 (xx) 1999-03-22
EP0915870B1 (en) 2002-09-25
US6228877B1 (en) 2001-05-08
DE69715870T2 (de) 2003-06-18
CA2262089A1 (en) 1998-02-05

Similar Documents

Publication Publication Date Title
CO4900054A1 (es) Pirroles sustituidos
CO4900055A1 (es) 3,4-di-indolil pirroles
ES2052704T3 (es) Analogos de benzodiacepina.
ES544523A0 (es) Un procedimiento para la preparacion de derivados de benzodiazefinas.
NO995455D0 (no) 4-Fenylpiperidinforbindelser
CO5031247A1 (es) Compuestos triciclicos sustituidos
ES2036551T3 (es) Compuestos heterociclicos.
PT1064281E (pt) Derivados de distamicina benzo-heterociclicos processo para os preparar e a sua utilizacao como agentes antitumorais
ES2150613T3 (es) Compuestos benzo-condensados de acepinona y piperidinona, utiles como inhibidores de ace y nep.
ATE23536T1 (de) Neue muramylpeptide und verfahren zu ihrer herstellung.
CO4960660A1 (es) Derivados de 5-aroil-pirrol-2-ilmetilareno, composiciones farmaceuticas que las contienen y metodos para la preparacion de estos compuestos
ECSP972205A (es) Pirroles sustituidos
ECSP972206A (es) Pirroles sustituidos
ES2140552T3 (es) Derivados indol como inhibidores de la 5-alfa-reductasa-1.
PE25195A1 (es) Sintesis de l-aspartil-d-aminoalcanoil-(s)-o-alquilbencil amida utilizada como endulzante artificial
AR241441A1 (es) Procedimiento para la obtencion de nuevos derivados del acido 4-benzoil-5hidroxi-benzociclobuten-1-carboxilico y sus sales.
ES2129784T3 (es) Procedimiento de preparacion de un compuesto intermediario de sintesis y su uso.
DE69525145T2 (de) Carbamoylmethylharnstoffderivate
ECSP082418A (es) Heterociclos biciclicos disustituidos, su preparacion y su utilizacion como medicamentos
ES551489A0 (es) Procedimiento para la obtencion de 5-sulfonamido-1-aril-pirazoles.
AR007463A1 (es) Colorantes monoazoicos sustituidos por grupos haloalquilcarbamato y sulfonilfluoruro
ECSP982418A (es) Heterociclos biciclicos- disustituidos, su preparacion y su utilizacion como medicamentos
CO5550438A2 (es) DERIVADOS DEL ACIDO 5,6,6a,1 1b-TETRAHIDRO-7OXA-5-AZABENZO [C] FLUORENO-6-CARBOXILICO SUSTITUIDOS COMO ANTAGONISTAS DE NMDA
GR3007320T3 (es)
ES2071346T3 (es) Tetrapeptidos que derivan de antibioticos dalbaheptidos.